Randomized trial demonstrates improved survival in patients with metastatic colorectal cancer, highlighting therapy's effectiveness.
The addition of bevacizumab to fluorouracil-based combination chemotherapy results in statistically significant and clinically meaningful improvement in survival among patients with metastatic colorectal cancer.
No takes yet. Share an insight, caveat, or question.
Hurwitz et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: